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ABSTRACT
Introduction: Self-administration of medicines
or dietary supplements without any physician’s
advice is a widespread behavior and appears to
be more frequently practiced by women.
Moreover, reasons to self-administer products
are often pains and injuries especially among
athletes who might also use remedies to
improve physical performance. The objective
of this study was thus to assess the prevalence of
self-administration of medicines and dietary
supplements as well as its determinants among
female amateur runners.
Methods: Our sample was comprised of women
who took part in amateur running events. Data
regarding self-administration of substances,
exclusively aiming at being physically
prepared for the running event (i.e., intake the
week before), were collected through an
anonymous self-administered questionnaire
including four specific themes (i.e., general
information, self-administered medicines and
dietary supplements, context of
self-administration of substances and
knowledge of the anti-doping regulations).
Results: A total of 136 women, with a median
age of 39 years (interquartile range: 27–47),
volunteered. Among them, 34.6% reported
self-administration of medicines during the
period immediately preceding the running
event, with the aim to be physically prepared.
More than one third (33.8%) also declared
self-administration of dietary supplements.
Furthermore, we observed that about 8.1% of
the sample had consumed a potentially doping
substance. After adjustments for confounding
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variables, the probability of self-administration
of products (medicines or supplements)
increased significantly with the intensity of the
activity and the membership in a sports club.
Conclusions: Our study showed that
self-administration of products among female
runners seems to be a widespread behavior,
where the intensity of the sports practice and
the network of runners seem to influence the
decision to resort to this behavior.
Keywords: Amateurs sports; Dietary
supplements; Female runners;
Self-administration of products;
Self-medication; Vitamin and mineral
supplements
INTRODUCTION
Self-administration of products for their
presumed health benefits and without any
medical supervision is a current behavior and
represents a public health concern.
Self-administration of vitamin or mineral
supplements is indeed a widely practiced
behavior. Moreover, many individuals also
resort to self-medication (i.e.,
self-administration of medicines). Although no
consensus on a universal definition exists,
self-administration of drugs involves
consumption, without any health
professionals’ advice, of over-the-counter drugs
but also of formerly prescribed medicines [1, 2].
While an appropriate self-administration of
these remedies can provide some benefit (e.g.,
patient empowerment, reduction of health
expenditure by government) [3], a
non-responsible use can lead to serious health
hazards [6, 8] (e.g., misuse, wrong dosage,
adverse health events or interactions). The
results of three recent studies [4–6]
demonstrated that self-administration of
substances is more prevalent among women
probably because they seem more willing than
men to recognize and voice the symptoms of
health ailments [7].
Especially among amateur athletes,
self-administration of medicines or
supplements is undertaken for various reasons.
Primarily, they are frequently exposed to pain,
tiredness, injuries and difficulties with recovery
and therefore decide to resort to
self-administration of various products. They
can also deliberately use dietary supplements
and medicines in order to enhance their
physical appearance and performance [9].
Moreover, because remedies usually
self-administered in order to treat common
health problems may contain substances
prohibited by the World Anti-Doping Code
[10], their consumption exposes amateur
athletes to inadvertent doping [11], which
could lead to unexpected penalties, although
these controls seem uncommon in the amateur
sports community.
Unfortunately, only limited epidemiological
data on self-administration of products by
amateur athletes exist. The few existing studies
mainly focus on one particular product (i.e.,
only analgesics or only over-the-counter drugs)
[12, 13]. These surveys observed a high
prevalence of this behavior but did not
distinguish self-administration of substances as
a lifestyle habit from self-administration of
substances at shorter term, with the aim to be
physically prepared for a sporting event (i.e.,
during the period immediately preceding
competition). Therefore, the objective of the
current survey was to identify the prevalence of
self-administration of products in the amateur
sports population who aim at being physically
prepared for specific sports events. We focused
especially on female amateur runners because of
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the still growing interest in this sport, especially
among women, and their propensity to
self-administer drugs or supplements more
than men [5]. Moreover, too sparse
information is available on the use of
supplements and medicines in this population.
METHODS
Participants
Our sample consisted of female volunteers who
participated in any of eight amateur running
events of 10 or 21 km in the Province of Lie`ge,
Belgium, between August 2014 and March 2015.
The different races were targeted on the basis of
our geographic and availability constraints.
There were no specific selection criteria except
that women had to be aged 18 years or more. All
women gave their written informed consent.
This study received the approval of the Ethics
Committee of the University Teaching Hospital
of Lie`ge under the reference 2014-173. All
procedures followed were in accordance with
the ethical standards of the responsible
committee on human experimentation (Ethics
Committee of the University Teaching Hospital
of Lie`ge, Belgium) and with the Helsinki
Declaration of 1964, as revised in 2013.
Informed consent was obtained from all
patients for being included in the study.
Parameters Investigated
Data were collected through an anonymous
self-administered questionnaire, specially
developed to gather information regarding
products that were self-administered by female
runners. Our questionnaire consisted of 24,
mainly closed, questions grouped into four
main themes: general information,
self-administered products, context of
self-administration of substances and
knowledge of the anti-doping regulations.
General Information
The questionnaire gathered self-reported
socio-demographic and anthropometric data.
It also asked about potential current illnesses.
The level and intensity of usual sports practice
(i.e., casual, amateur or professional, number of
activities and number of hours of sports
practice) were recorded. Women also had to
indicate the length of the race chosen on that
specific day (10 or 21 km) and whether they
were a member of a sports club.
Self-Administered Products
Female runners were also asked to list all
self-administered products they had consumed
with the aim of being physically prepared for
the competition. With the consumption of
vitamins and food supplements lasting
generally for a longer period than a drug, we
decided to establish two different thresholds:
within the last week for dietary supplements
and maximum last 24 h for medicines. The
following questions were asked to determine
whether women resorted to self-administration
or not: (1) ‘‘In order to be physically prepared for
this specific running event, have you consumed
vitamins and/or dietary supplements during the last
week, without a doctor’s advice?.’’ (2) ‘‘Over the past
24 h, during your physical preparation for this
event, have you taken medicines fighting against
cough/asthma/sore throat/headache/fever/blocked
nose/pains/stress/difficulty sleeping/decreasing
performance/other?’’ By listing the various
ailments against which athletes were likely to
fight by taking medicines, it allowed us to
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determine the reasons for this self-medication.
We also inserted control variables to verify
whether medicines were consumed with or
without any physician advice (and then,
self-administered) by asking the following
questions: ‘‘Were these medicines prescribed by a
doctor?’’ ‘‘If the medicine has been prescribed by a
doctor, was it in order to be physically prepared for
this running event?’’ Female runners were also
requested to indicate the name of every single
product in order to enable us to assess whether
they were part of the prohibited list of the
World Anti-Doping Agency.
Context of Self-Administration of Substances
We identified on which person’s advice, if any,
subjects of our sample consumed products (e.g.,
familial acquaintances, sports acquaintances,
colleagues), where products were acquired
(e.g., family medicine chest, from friends and
peers, at the pharmacy) and reasons to resort to
self-administration of these remedies (e.g., lack
of time, lack of financial means, symptoms that
did not require medical consultation). For each
of the questions enquiring about these, a list of
pre-established answers was proposed. However,
subjects had the opportunity to mention a
response not listed. Respondents could report
several sources and reasons.
Knowledge of the Anti-Doping Regulations
We enquired about knowledge of doping test
regulations and of the World Anti-Doping
Agency prohibited list. These four consecutive
questions were asked: ‘‘Do you know that an
official list of products, considered as doping,
prohibited in sports currently exists?’’ ‘‘Before
taking medicines, do you check if they figure on
this prohibited list?’’ ‘‘Do you know at which level of
competition you can be controlled and tested? If yes,
specify the level.’’ ‘‘Do you think you could be
controlled out of competition?’’
Data Collection Tool
Our questionnaire was created in collaboration
with experts in sports medicine, but also with
experts in survey methodology. It was
pre-tested in a sample of ten amateur athletes.
We also performed a post hoc reliability analysis
using a ‘‘test-retest’’ approach: 21 amateur
athletes responded to identical questions at
two different times but in an equivalent
context. A time interval of 15 days was
chosen. To determine the test-retest reliability,
the intraclass correlation coefficient (ICC) was
calculated for each item, constituting the four
main parts: general information, products
consumed, context of self-administration of
products and knowledge of the anti-doping
regulations. In summary, the ICC varied,
respectively, from 0.89 to 0.95, 0.61 to 0.94,
0.67 to 1.00 and 0.86 to 1.00. Specifically, for
questions allowing the calculation of the
prevalence of self-medication and of
self-administration of dietary supplements, the
ICC respectively ranged from 0.87 to 1.00.
Organization of Data Collection
Before the race, and then during the period
devoted to registration for the running event,
two investigators proposed to female
participants to answer the anonymous
self-administered questionnaire. Each
researcher had to count the number of refusals
to participate. If female runners volunteered,
the objectives of the survey were exposed orally
by the investigators. The investigators drew
participants’ attention to the importance of
providing all the requested data accurately,
reliably and completely. Investigators,
previously trained, remained available to
volunteers for additional information. Female
volunteers then placed the completed
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self-administered questionnaire in an opaque
sealed urn to strictly respect the anonymity.
Statistical Analysis
All continuous data being not normally
distributed, we reported them as median and
percentiles. Normality of the different data was
tested using the Shapiro-Wilk test. We
compared the characteristics of the individuals
who took self-administered substances with
those who did not by means of the
Mann-Whitney test for quantitative data not
normally distributed and the chi-square test for
qualitative variables. A logistic regression was
also performed to describe the relation between
the dichotomous dependent variable (i.e.,
self-administration of products or not) and
potential explanatory variables. We considered
as potential explanatory variables those having
a p value lower than 0.10 in the descriptive
analysis. The statistical analyses were performed
using the software Statistica 10. Results were
considered as statistically significant when
two-tailed p values were less than 0.05.
RESULTS
A total of 136 female runners responded to the
survey. The median age in our sample was
39 years [interquartile range (IQR): 27–47].
Participants’ characteristics are summarized in
Table 1. Note also that 13 women refused to
participate in our survey. The non-participation
rate thus amounts to 8.72%.
Self-Administration Of Medicines
Among the 136 respondents, 47 female runners
(34.6%) had taken self-medication drugs during
the period immediately preceding the running
(i.e., maximum last 24 h) with the aim of being
physically prepared for the competition. The
main reasons reported by women who indicated
self-medication were: to reduce pain (14.0%), to
reduce headaches (11.8%) and to improve their
physical performance (6.6%) (Table 2).
Non-opioid analgesics and nonsteroidal
anti-inflammatory drugs were the two
therapeutic agents most often cited. Moreover,
11.1% (out of the 47 women who used
medicines) consumed two drugs or more.
Table 3 shows that no differences were found
between female runners who used
self-medication drugs with those who did not
regarding age, body mass index, level of
education, number of health ailments and
Table 1 Characteristics of female runners
Variables N % Median
(P25–P75)
Age 136 39 (27–47)
Body mass index 136 21.8 (19.9–23.6)
Level of education
Primary school 2 1.5
Secondary school 43 31.6





Number of sports activities 136 1 (1–2)
Number of hours of
weekly sports activity
136 5 (3–7)
Membership in a club
Yes 79 58.1
No 57 41.9
Length of the race
10 km 97 71.3
21 km 39 28.7
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length of the race. Nonetheless, the median
number of sports activities and the median time
of sports practiced weekly were significantly
superior in the self-medicated group (p values
were, respectively, 0.04 and 0.01). Female
runners were also more likely to use
self-medication drugs if they were a member
of a sports club (p value = 0.001).
When we inserted all variables with p values
less than 0.10 into a logistic regression model,
we observed indeed that the probability to
self-medicate was 1.66-fold (95% CI:
1.06–2.61, p value\0.001) increased
depending on the number of sports activities,
1.13-fold (95% CI: 1.02–1.24, p value = 0.02)
increased depending on the number of hours of
weekly sports activity and 2.49-fold (95% CI:
1.07–5.81, p value = 0.03) depending on the
membership in a sports club.
Self-Administration of Dietary
Supplements
Among the 136 amateur runners, 46 women
(33.8%) declared having taken
self-administered vitamins or minerals during
the week preceding the running event. The
vitamins most frequently consumed were
vitamin D and vitamin C, respectively, taken
by 12.5% and 5.2% of the whole study
population. The main mineral consumed was
magnesium (15.4%). Female runners asserted
having mainly consumed these dietary
supplements to prevent a potential health
problem. Characteristics of women who took
self-administered supplements compared to
those who did not are presented in Table 4.
Women who were members of a sports club
were significantly more likely to consume
vitamins and minerals (p value \0.001)
without medical advice. A multivariable
logistic analysis confirmed that the more
intense the physical activity was in terms of
number of sports practiced, the higher the
probability of using dietary supplements (OR
1.84, 95% CI 1.16–2.92, p value = 0.008). It
confirmed, as well, that women who were
members of a sports club were more likely to
use vitamin or mineral supplements (OR 4.95,
95% CI 2.02–12.11, p value\0.001).
Context of Self-Administration
of Substances
Among the 136 female runners, 16.9% declared
having taken both self-administered dietary
supplements and drugs. We therefore assessed
the association between the two behaviors: the
self-administration of one type of substance
(medicines or supplements) was positively and
significantly associated with the probability to
resort to self-administration of the other
substance (supplements or medicines,
respectively) (OR 2.75, 95% CI 1.31–5.78,
p value\0.05).
When asked on whose advice women
consumed these products, most of them
(43.4%) replied doing so on their own
initiative. They also answered following advice
of sports acquaintances (35.3%) and of family
members (23.5%). Regarding where dietary
supplements and medicines were obtained
Table 2 Self-reported indications for self-medication




Improving performance 6.6 Vitamin D
Blocked nose 6.6 Pseudoephedrine
Stress 3.7 Trazodone
Asthma 1.5 Salbutamol
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(Fig. 1), women mainly answered ‘‘at the
pharmacy’’ and ‘‘from the family medicine
chest’’ (also supplied by the formerly
prescribed drugs). The acquisition of
substances on the Internet and from the circle
of acquaintances was also mentioned.
Doping Potential of Consumed Products
Among women who mentioned self-medication
(34.6%), 23.4% consumed potentially doping
substances, which represents 8.1% of the total
sample. Two individuals (1.5%) admitted to
having consumed cannabis, a formally
forbidden substance, in competition. Six
female runners (4.4%) disclosed having
inhaled, without any professional supervision,
salbutamol or formoterol, which are potentially
doping substances, depending on the dose and
the medical context. Pseudoephedrine, another
potentially doping substance, contained in




Among the 136 runners, 26.5% declared
ignoring the existence of an official list
enumerating substances considered as doping
products in sports. Among the remaining 73.5%
having knowledge of this list, 52.9% admitted
never consulting it. Furthermore, 25.7% of the
women assured knowing from which level of
Table 3 Characteristics comparison between women who self-medicated and women who did not
Variables Self-medication (N5 47) No self-medication (N5 89) p value
n % Median (P25–P75) n % Median (P25–P75)
Age 47 40 (29–51) 89 36 (26–47) 0.33
Body mass index 47 21.5 (21.1–24.3) 89 22.4 (20.4–24.2) 0.17
Level of education 0.74
Primary school 1 2.1 1 1.1
Secondary school 14 29.8 29 32.6
Post-secondary education 30 63.8 58 65.2
Doctorate 2 4.3 1 1.1
Number of health ailments 47 0 (0–1) 89 0 (0–0) 0.51
Number of sports activities 47 2 (1–3) 89 1 (1–2) 0.04
Number of hours of weekly sports activity 47 6 (3–12) 89 4 (3–6) 0.01
Membership in a club 0.001
Yes 36 76.6 43 48.3
No 11 23.4 46 51.7
Length of the race 0.83
10 km 33 70.2 64 71.9
21 km 14 29.8 25 28.1
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competition a doping test could be done, but
47.6% of them were wrong.
DISCUSSION
Prevalence of Self-Medication
Around one-third of female athletes declared
using medicines or dietary supplements without
medical supervision during the period
immediately preceding the running event.
Moreover, 16.9% used both self-administered
medicines and dietary supplements, showing
that female runners consuming diverse
supplementations significantly tend to use
medicines also, and vice versa.
Other studies looking at the prevalence of
self-medication in amateur athletes [12, 14]
showed a slightly higher prevalence than that
observed in our results (60% or more, compared
to around 30% in our survey). Such
discrepancies can easily be explained: these
studies were only interested in self-medication
as a lifelong habit. Indeed, this behavior is
practiced in usual lifestyles by most individuals
of the general population. In our case, we
focused on self-administered drugs especially
in order to be physically prepared for a specific
sports event. This procedure allowed us to
highlight short-term risks of this kind of
behavior. Our results are more in line with a
large study [13], carried out on male and female
Table 4 Characteristics comparison between women who self-administered dietary supplements and women who did not
Variables Self-administration of dietary
supplements (N5 46)
No self-administration of
dietary supplements (N5 90)
p value
n % Median (P25–P75) n % Median (P25–P75)
Age 46 42.5 (32.0–51.0) 90 35.5 (25.0–46.0) 0.07
Body mass index 46 21.3 (19.8–23.4) 90 21.9 (19.9–23.6) 0.70
Level of education 0.62
Primary school 0 0.0 2 2.2
Secondary school 15 32.6 28 31.1
Post-secondary education 29 63.0 59 65.6
Doctorate 2 4.4 1 1.1
Number of health ailments 46 0 (0–01) 90 0 (0–1) 0.60
Number of sports activities 46 2 (1–2) 90 1 (1–2) 0.005
Number of hours of weekly sports activity 46 6 (3–7) 90 4 (3–7) 0.282
Membership in a club \0.001
Yes 38 82.6 41 45.6
No 8 17.4 49 54.4
Length of the race 0.09
10 km 37 80.4 60 66.7
21 km 9 19.6 30 33.3
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runners, which showed that up to 49% of
athletes consume drugs on their own initiative
just before a marathon. However, this study




In our research, it was not surprising to detect
an increase in the probability to self-administer
various products with the intensification of
physical activity required. Nevertheless, the
fact that this probability also increases when
amateur runners are members of a sports club
seems more unexpected. Some studies [15–17]
suggested that social environment (e.g., family
members and peers) prompted subjects to
consume health remedies without physician’s
advice. In our study, a similar observation
seemed clear: female amateur runners stated
seeking advice from their family members and
their sports acquaintances. Some even reported
obtaining substances from their circle of
acquaintances. A recent meta-analysis [18] also
highlighted the importance of social influence
in doping intentions.
Moreover, in accordance with other studies
[19, 20], the two therapeutic agents most
consumed by the female runners in our
sample were non-opioid analgesics and
nonsteroidal anti-inflammatory drugs
(NSAIDs). However, using these
pharmaceutical agents could lead to an acute
risk of worsening traumatic injuries [21], and
unexpected adverse effects related to these
drugs may also occur (e.g., gastrointestinal,
cardiovascular and renal disorders). In our
study, numerous women asserted using several
active substances in a combined way. The risks
of drug interactions are thus multiplied and
could lead to harmful consequences.
Regarding where products were obtained, the
female runners frequently mentioned the
family medicine chest. This probably suggests
that these subjects consumed formerly
prescribed drugs on their own initiative, which
is an understudied practice but which requires
particular attention. In addition, we noted the
acquisition of substances on the Internet. The
online purchase is, nonetheless, sometimes
unreliable: provenance and quality of
substances are not always controlled.
Doping Potential of Products
and Knowledge of the Anti-Doping
Regulations
Among female runners who consumed products
without medical supervision, 23.4% have
consumed potentially doping substances.
Except for cannabis, which is banned in









Fig. 1 Source of medicines and dietary supplements
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competition, the other substances are
prohibited above a predefined threshold, in
and out of competition, with the exception
made of a therapeutic use exemption [22].
Deplorably, it has been shown that some
dietary supplements contain illegal doping
substances [23, 24]. Women in our sample
were likely to use dietary supplements, which
they rightly supposed as legal because sold as
such, but unfortunately illegally contained
doping substances. This could favor a better
performance and exposes athletes, potentially
and unconsciously, to the risks of inadvertent
doping.
Doping intentions can be highlighted within
our sample. Indeed, among female runners who
took self-administered products, nearly 7%
clearly indicated consuming substances to
improve their sports performances. This
figure could be even more dramatic as we can
hypothesize that some individuals declared
having used a product for a therapeutic
purpose when, in fact, they used it with the
aim to enhance their physical performance.
This is particularly true for drugs known for
their non-medical use (no therapeutic purpose),
such as beta 2-agonists [25], consumed by some
female runners in our sample.
We also noted a lack of women’s knowledge
regarding world anti-doping regulations.
Indeed, controls can be conducted at any
levels of competition, and the anti-doping
regulations also include the possibility of
control outside competition [10]. More
surprisingly, more than one out of four female
runners ignored the existence of the World
Anti-Doping Agency prohibited list, and most
of those who knew it declared never consulting
it. These observations are similar to those made
in a previous study [26] demonstrating that,
generally, athletes have limited knowledge of
anti-doping regulations.
Contributions and Limitations of Our
Survey
This study has some strengths. We had the
opportunity to collect a limited but sufficient
sample to highlight behaviors of
self-administration of various products among
female runners. In other published studies,
researchers focused on lifestyle habits related
to self-administration of products but did not
objectivize this behavior during the period
immediately preceding the competition. The
way we proceeded, with our questionnaire
involving a particularly short recall period, we
obtained comprehensive data about drugs and
supplements consumed without health
professional advice and with the aim to be
better prepared for the race. Moreover, the
perspective in which we envisaged this topic
allowed us to collect a wide panel of medicinal
behaviors at risk for amateur athletes. We also
drew up a list of substances presenting a doping
power and those being able to lead to a positive
result to a doping test. Our questionnaire also
shows a good reliability, as indicated by the
values of the ICC (i.e., 0.9 and 1.0) for the two
main outcomes. This means that if the
evaluation by means of our questionnaire
could be performed at different times, in a
similar context of testing, it would highlight the
same results.
Our research also has a number of
limitations that need to be considered. First of
all, we opted for a convenience sampling, which
does not allow us to generalize our results to the
whole population of female runners. Then,
even if several statically significant relations
were established in our sample, it is essential to
interpret these with caution by considering
them in the strict frame of our survey.
Furthermore, the information bias, due to
self-declaration, is the main bias inherent to
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our investigation. Actually, all the data were
self-reported and could have been relayed,
voluntarily or not, in an inaccurate or
erroneous way. Moreover, the topic
approached by our study is subject to social
desirability bias, despite a strict guarantee of
anonymity. Therefore, we can suppose that
prevalence of the practices of
self-administration of medicines and dietary
supplements has been underestimated in our
survey. This social desirability bias is also
probably related to refusal to participate
(non-participation rate: 8.72%) and therefore
also leads to a possible underestimation of the
actual prevalence of the practice.
A season bias could also influence our
findings. Indeed, in the data collected in
February 2015, we observed a higher
consumption of decongestant drugs (some
being on the World Anti-Doping Agency
prohibited list) than for the rest of the
collection period.
CONCLUSIONS
Our study underlined that self-administration
of medicines and dietary supplements among
female amateur runners seems frequently
practiced and is influenced by the intensity of
physical activity and peers. A promotion of a
responsible use of medicines and supplements is
therefore necessary to prevent drug
misadventures and protect female athletes’
health.
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